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Abstract
The Th1/Th2 balance represents an important factor
in the pathogenesis of renal ischemia-reperfusion
injury (IRI). In addition, IRI causes a systemic
inflammation that can affect other tissues, such as
the lungs. To investigate the ability of renal IRI to
modulate pulmonary function in a specific model of
allergic inflammation, C57Bl/6 mice were immunized
with ovalbumin/albumen on days 0 and 7 and
challenged with an ovalbumin (OA) aerosol on days
14 and 21. After 24 h of the second antigen challenge,
the animals were subjected to 45 minutes of ischemia.
After 24 h of reperfusion, the bronchoalveolar lavage
(BAL) fluid, blood and lung tissue were collected for
analysis. Serum creatinine levels increased in both
allergic and non-immunized animals subjected to IRI.
However, BAL analysis showed a reduction in the total
cells (46%) and neutrophils (58%) compared with
control allergic animals not submitted to IRI. In addition,
OA challenge induced the phosphorylation of ERK
and Akt and the expression of inducible nitric oxide
synthase (iNOS) and cyclooxygenase-2 (COX-2) in
lung homogenates. After renal IRI, the phosphorylation
of ERK and expression of COX-2 and iNOS were
markedly reduced; however, there was no difference
in the phosphorylation of Akt between sham and
ischemic OA-challenged animals. Mucus production
was also reduced in allergic mice after renal IRI. IL-4,
IL-5 and IL-13 were markedly down-regulated in
immunized/challenged mice subjected to IRI. These
results suggest that renal IRI can modulate lung
allergic inflammation, probably by altering the Th1/
Th2 balance and, at least in part, by changing cellular
signal transduction factors.
Introduction
Allergic asthma is a complex disease that
simultaneously involves the participation of several cells,
cytokines and inflammatory mediators. It is characterized
by a specific pattern of airway inflammation, involving
eosinophils and lymphocytes with a prevalence of the Th2
sub-population. Moreover, asthma induces structural
changes in the airways (remodeling) that include an
increased deposition of collagen in the bronchi, sub-
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epithelial fibrosis, hypertrophy and hyperplasia of the flat
airways muscle, angiogenesis and an increase in mucus
secretion [1].
Several reports in the literature indicate that diseases
with a Th1 pattern could modulate the inflammatory
response in asthma [2-5]. A possible cause for this
modulation is an increase in IL-10 production. The
protective effect of IL-10 in asthma includes the induction
of IgG [6], the modulation of the expression of IL-4 and
IL-5 cytokines [7] and the inhibition of the production of
histamine and other inflammatory mediators released by
the mast cells [8]. These effects of an antigen challenge
are the result of the activation of intracellular signaling
cascades, including the mitogen-activated protein kinases
(MAPK), which include the extracellular signal-regulated
kinase (ERK) [9]. In addition, protein kinase B (Akt) is a
downstream regulator of phosphatidylinositol 3‘-kinase
(PI3K) and is implicated in the PI3K-mediated regulation
of nuclear factor-κ B (NF-κB), an important transcription
factor for pro-inflammatory mediators [10].
The pathogenesis of renal ischemia-reperfusion
injury (IRI) is complex and still not fully understood.
However, the inflammatory response is thought to be an
important pathogenic component, and other factors,
including endothelium lesion, reactive oxygen and nitrogen
species and the production of lipid mediators by the
sub-lethally damaged tubular cells, have also been
implicated [11-13]. Experimental evidence has suggested
that the Th1/Th2 balance represents an important factor
in the pathogenesis of renal IRI. Corresponding evidence
demonstrating that the Th1 profile is an important factor
for the secretion of monocyte chemoattractant protein-1
(MCP-1) has also been presented in studies from our
group [14].
Experimental models of respiratory stress syndrome
in adults are characterized by the accumulation of
neutrophils in the lung and an increase in microvascular
permeability [15]. Acute respiratory distress syndrome
and renal IRI frequently co-exist in patients in the
intensive treatment units, and this combination is
associated with higher mortality. Rabb et al. [16] and
Kramer et al. [17] demonstrated that renal IRI can
result in increased lung vascular permeability, similar to
that observed in adults with acute respiratory distress
syndrome. We recently demonstrated that mice subjected
to IRI develop lung inflammation with increased
expression levels of COX2, iNOS and prostaglandins
E2. In addition, IRI induces the migration of inflammatory
cells, such as neutrophils, lymphocytes and macrophages
in the lung [18].
Clearly, more studies are needed to elucidate the
crosstalk between the kidney and lungs after an acute
renal injury (ARI). The aim of the present study was to
investigate the influence of renal IRI on lung dysfunction
in a model of pulmonary allergic reactions. We evaluated
the expression levels of the IL-1β, IL-2 and IL-12 Th1
cytokines and the IL-4, IL-5 and IL-13 Th2 cytokines,
the phosphorylation of ERK and Akt, the expression levels
of COX-2 and iNOS, inflammatory cell infiltration and
mucus production.
Materials and Methods
Animals
Male C57Bl/6 mice weighing 20-25 g, 6-8 weeks old, from
our own animal facilities were housed in a room with 12 h light-
dark cycle with water and food ad libitum. Animal care and
research protocols were in accordance with the principles and
guidelines adopted by the Brazilian College of Animal
Experimentation (COBEA) and approved by the Biomedical
Sciences Institute/USP – Ethical Committee for Animal Research
(CEEA).
Immunization protocol
Mice were sensitized on days 0 and 7 by intraperitoneal
injection of a mixture containing 50 µg of ovalbumin (OA) and
1 mg of aluminium hydroxide [Al(OH)3] in saline (a total volume
of 0.2 mL). At 14 and 21 days after first immunization the animal
were challenged by exposure to an aerosol of OA (grade III,
Sigma) generated by an ultrasonic nebulizer (ICEL US-800, SP,
Brazil) delivering particles of 0.5-10 µm diameter at approximately
0.75 cc/min for 20 min. The concentration of OA in the nebulizer
was 2.5% wt/vol. The control group consisted of animals
immunized as described and challenged with saline solution,
or non-immunized animals challenged with OA aerosol as
above.
Experimental model of IRI
Surgery was performed 24 hours after the second OA
challenge, as previously describe [19]. Mice were anesthetized
with Ketamine-Xylazine (Agribrands do Brazil, São Paulo,
Brazil). A midline incision was made and both renal pedicles
were cross-clamped. In the ischemia period, animals were kept
well hydrated with saline and at a constant temperature (~37°C)
through a heating pad device. Forty-five minutes later,
microsurgery clamps were removed, abdomen was closed in
two layers and animals were placed in single cages, warmed by
indirect light until complete recovery from anesthesia. Animals
were kept under adjustable conditions until sacrifice at 24 hours
of reperfusion.
Analysis of renal function
Serum creatinine was used for evaluation of renal function
after IRI. Blood samples were collected 24 hours after ischemic
surgery from the abdominal inferior cava vein immediately
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before induced death. Serum creatinine levels were determined
by absorbance readings at 520nm in spectrophotometer using
modified Jaffé technique.
Bronchoalveolar lavage
The animals were sacrificed by injection of ketamine/
xylasine (50 µL of a 100 mg/mL solution, i.p.) 24 h after ischemia
or sham surgery. A tracheal cannula was inserted via a
midcervical incision and the airways were flushed twice with 1
ml of phosphate buffered saline (PBS, pH 7.4 at 4°C).
Total and differential cell counts
The bronchoalveolar lavage (BAL) fluid was centrifuged
at 170 g for 10 min at 4°C, the supernatant was removed, and
the cell pellet was resuspended in 0.5 mL of PBS. One volume
of a solution containing 0.5% crystal violet dissolved in 30%
acetic acid was added to nine volumes of the cell suspension.
The total number of cells was determined by counting in a
hematocytometer. Differential cell counts were performed after
cytocentrifugation and staining with hematoxylin-eosin (Hema
3).
Western blot
Lung was collected after BAL fluid and homogenized in 1
mL of cold PBS by sonication in ice-cold lyses buffer containing
150 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM sodium
orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 50 mM
NaF, and 1 µg/mL leupeptin, followed by centrifugation at 10000
g for 20 minutes at 4°C. Protein content in the supernatant was
determined using the BCA protein assay reagent kit (Pierce),
according to the manufacture´s protocol. Samples containing
20 µg protein were separated on 10% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) gels and
transferred to nitrocellulose membrane using the Biorrad Mini-
Gel system and trans-blot® SD-semidry Transfer cells. For
immunoblotting, the nitrocellulose membranes were incubated
in TBS-T buffer (150 mM NaCl, 20 mM Tris, 1% Tween 20, pH
7,4) containing 5% non-fat milk dried milk, for 1 h. After that,
the blots were washed with TBS-T and probed with antibodies
(1:500 dilution) directed against phospho-ERK 1/2 MAPK
(Thr183/Tyr185), or phospho-Akt (Ser473), or COX-2 or iNOS
(1:1000) for 2 h at room temperature, then were washed three
times with TBS-T, and incubated with 1:2000 dilution of
peroxidase-conjugated monoclonal anti-rabbit IgG for 1 h at
room temperature. Protein bands at 42/44 kDa (ERK), 60 kDa
(Akt), 72 kDa (COX-2) or 130 kDa (iNOS) were identified
by comparison with RainbowTM protein molecular weight
markers. The immunocomplexed peroxidase-labeled antibodies
were visualized by an ECL chemiluminescence kit following
manufacturer´s instruction (Amersham) and exposed to
photographic film. Finally, blots were stripped with 200 mM
glycine, pH 3.0, for 10 min, washed with TBS-T three times
for 30 min each, and reprobed with β-actin (1:10.000), followed
by anti-mouse secondary antibody (1:2000). The band
densities were determined by densitometric analysis using
the AlphaEaseFCTM program (Alpha Innotech, San Leandro,
CA, USA). Density values of bands were normalized to the
total β-actin present in each lane and expressed in
percentage of control.
Cytokine gene profiles
Lung samples were quickly frozen in liquid nitrogen. Total
RNA was isolated from lung tissue using TRizol Reagent
(Invitrogen, USA) and RNA concentration was determined by
absorbance readings in spectrophotometer at 260nm and
280nm. First-strand cDNA were synthesized using the MML-V
reverse transcriptase (Promega, USA). All experimental
protocols for Real-time PCR were based on the manufacturer´s
recommendation using the TaqMan gold RT-PCR Core
Reagents Kit (PerkinElmer/Applied Biosystems). Primers and
probes were purchased from Applied Biosystems. Cycling
conditions were as follows: 10 min at 95°C, followed by 45
cycles of 15s at 95°C and 1min at 60°C. The amount of the
target gene was normalized first to an endogenous reference
(HPRT) and then relative to a calibrator (sample with the
lowest expression, namely, sham-operated animals), using the
2-ΔΔCt method. Hence, steady-state mRNA levels were
expressed as an n-fold difference relative to the calibrator.
Analyses were performed with the Sequence Detection
Software 1.9 (SDS).
Histopathologic analysis
Lungs were removed after (BAL) fluid collection, perfused
via the right ventricle with 10 mL PBS to remove residual blood,
immersed in 10% phosphate-buffered formalin for 24 h and
then in 70% ethanol until embedding in paraffin. Tissues were
sliced and 5 micron sections and stained with periodic acid-
Schiff (PAS)/hematoxylin for evaluation of mucus-producing
cells. The intensity of mucus production was evaluated as
previously describe [20], in each preparation and scores from 0
to 3 were attributed: 0 when none of the bronchi show any sign
of mucus; 1, 2 or 3 when 25%, 50% or more than 50% of the
bronchi epithelium was covered by mucus. Values represent
the sum of 10 bronchi scored randomly at x250 magnification.
Statistical analysis
Data are expressed as the means ± S.E.M. Statistical
evaluation of the data was carried out by analysis of variance
(ANOVA) and sequential analysis of differences among means
was done by Tukey’s contrast analysis. A P value lower than
0.05 was considered to be significant. P<0.05, P<0.01 and P<0.001
were marked with one, two or three asterisks, respectively.
Results
Renal dysfunction
C57Bl/6 mice were subjected to 45 minutes of renal
ischemia. After 24 h of reperfusion, blood was collected
to evaluate renal function by measuring serum creatinine
levels. The ischemic group showed increased serum
creatinine compared to controls (1.14±0.14 vs. 0.44±0.02
mg/dl). Serum creatinine levels were also increased in
the immunized ischemic group (1.0±0.11 vs. 0.34±0.01
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mg/dl) compared to the immunized sham group. However,
serum creatinine levels in the immunized ischemic group
were not different from those in the ischemic group. These
results show that IRI causes severe renal dysfunction in
both immunized and non-immunized ischemic animals
(Fig.1).
Cells in BAL after IRI
To analyze the systemic effects of renal IRI on the
lungs, analyses of the BAL fluid were performed 24 hours
after renal ischemic surgery in the immunized and non-
immunized groups. In the non-immunized groups, the
number of total cells was significantly higher in the
ischemic animals than in the sham animals (32.1±2.8 vs.
17.5±2.5). The sham immunized group presented a higher
number of total cells compared to both the sham non-
immunized group (55±4 vs. 17.5±2.5) and the ischemic
non-immunized group (55±4 vs. 32.1±2.8). When the
immunized animals were subjected to ischemia, the
increase in the number of cells was abolished. Differential
cell counting showed that the number of neutrophils was
increased after IRI (9.08±4.5 vs. 0.2±0.1) and in the sham
immunized group (9.3±2.5 vs. 0.2±0.1). However, in the
immunized ischemic group, the increase in the number of
neutrophils was abolished. The number of eosinophils was
increased in the sham immunized group (5.2±1.5 vs.
0.47±0.3) and was reduced after IRI (0.73±0.06 vs.
5.2±1.5) (Fig. 2).
Mucus production
In another series of experiments, the intensity of
mucus production was evaluated in the bronchi (n=10)
and scored from 0 to 3 as described in the Materials and
Methods. In the sham and ischemic groups, none of the
bronchi contained mucus (score 0), while the immunized
group had an average score of 2.5. The immunized
ischemic group showed significantly inhibited mucus
production (2.5 vs. 0.9). Mucus plugs were not observed
in any group (Fig. 3).
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Fig. 1. Renal function. Serum creatinine was measured after
renal ischemia and reperfusion injury, which was carried out
via a bilateral clamping of renal pedicles for 45 min followed by
24 h of reperfusion. The results are expressed as the means ±
S.E.M. of 5 animals. * p<0.01 compared to the respective sham
group.
Fig. 2. Total cells, neutrophils and eosinophils in
bronchoalveolar lavage (BAL) fluid. BAL was processed 24 h
after the renal ischemia and reperfusion injury. The cells were
counted in a hematocytometer, and differential cell counts were
performed after cytocentrifugation and staining with
hematoxylin-eosin. The results are expressed as the means ±
S.E.M. of 5 animals. * p<0.01 compared to the sham group, and
# p<0.05 compared to the respective sham group.
Cell Physiol Biochem 2012;29:523-532
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Expression of COX-2 and iNOS in pulmonary
tissue
Two molecules linked to endothelial cell dysfunction,
COX-2 and iNOS, were quantified in the lung using
Western blot. Lung tissue was collected 24 h after the
renal ischemic surgery. The density of bands in the
Western blot demonstrated that both molecules were
increased in the ischemic groups at 24 hours compared
to sham-operated animals (COX-2: 1084±97.09 vs.
129±10; iNOS: 1172±126.2 vs. 529±59). Both molecules
were increased in the immunized group (COX-2:
1867±69.4 vs. 1084±97.09; iNOS: 2428.5±185.7 vs.
1172±126.2) compared to the ischemic group, and in
the immunized ischemic group, the levels of COX-2 and
iNOS were significantly decreased (COX-2: 1867±69.4
vs. 1186.7±190.5; iNOS: 2428.5±185.7 vs. 985±132.3)
(Fig. 4).
Fig. 3. Mucus index. Lung tissue was harvested 24 h after
renal ischemia and reperfusion injury. Mucus production was
analyzed by staining with periodic acid schiff. The results are
expressed as the means ± S.E.M. of 5 animals. ** p<0.01
compared to the sham group, and # p<0.05 compared to the
respective sham group.
Fig. 4. COX-2 and iNOS expression. Lungs were collected 24
h after renal ischemia and reperfusion injury to quantify the
expression levels of COX-2 and iNOS by Western blot. The
graphs represent the density values of bands that were
determined by densitometry analysis and normalized to the
total β-actin present in each lane. The results are expressed as
the means ± S.E.M. of 5 animals. * p<0.01 compared to the
sham group, and # p<0.05 compared to the respective sham
group.
Fig. 5. OA-induced Akt (A) and ERK (B) phosphorylation in
the lung tissue 24 hours after saline or OA challenge. ERK and
Akt phosphorylation were assessed by Western blot analysis.
The antibodies recognized the phosphorylated residues Thr-
183 and Tyr-185 of p44/42 MAPK and Ser-473 in Akt. The
Western blot is a representative of 4 independent experiments.
Protein expression was quantified using AlphaEaseFCTM
software. The values represent the means ± S.E.M of 4 animals
per group. * p<0.01 compared to the respective sham group.
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IRI modulates the OA-induced phosphorylation
of signaling pathways
Twenty-four hours after OA challenge, the lungs
were removed, as described in the Materials and Methods,
and the phosphorylation of ERK and Akt were analyzed
by Western blot. Fig. 5 shows that OA challenge was
able to induce the phosphorylation of both molecules, ERK
(2 fold) and Akt (3.3 fold), in the lung compared to the
control group, which received saline aerosol. Interestingly,
OA-challenged mice subjected to IRI showed an increase
in ERK phosphorylation (1.5 fold) compared to sham OA-
challenged mice. There was no difference in Akt
phosphorylation between the two groups.
Expression of cytokines in the lungs after renal
IRI
Real-Time PCR was used to quantify the expression
of IL-1β, IL-2, IL-12, IL-4, IL-5 and IL-13 in pulmonary
tissue after OA challenge and renal IRI. Lungs were
collected 24 hours after reperfusion. Ischemic mice
showed an increase in the expression of the Th1 cytokines
IL-1β (18.59±0.5), IL-2 (6.12±1.25) and IL-12
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Fig. 6. Cytokine expression. IL-1β, IL-2, IL-12, IL-4, IL-5 and IL-12 mRNA expression were evaluated using real-time PCR. Lungs
were harvested 24 h after the ischemic insult. The samples were normalized to the endogenous gene HPRT, and the sham group
was used as the calibrator. The results are expressed as the means ± S.E.M. of 5 animals * p<0.01 compared to the sham group,
and # p<0.05 compared to the respective sham group.
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(8.26±2.79) when normalized to the sham group but
did not present an up-regulation in the expression of
the Th2 cytokines IL-4, IL-5 and IL-13. However, the
sham immunized group showed increased expression of
IL-4 (2.84±0.08), IL-5 (23.26±1.99) and IL-13
(83.06±12.93). The immunized ischemic group showed
decreased levels of the Th2 cytokines IL-4 (84%), IL-5
(68%) and IL-13 (72%) when compared to the sham
immunized group (Fig. 6).
Discussion
The model we used to study allergic lung
inflammation consisted of immunization with ovalbumin
using aluminum hydroxide as an adjuvant, which was
followed 14 days later by two ovalbumin aerosol
challenges one week apart. This model presents many of
the characteristic features of allergic asthma, such as
eosinophil and lymphocyte infiltration, mucus production
and airway hyperreactivity [21].
Genetic differences among mouse strains with
regard to basal lung functions and airway responsiveness
have been reported previously [22]. In fact, some papers
have demonstrated that in BALB/c mice, the Th2 immune
response develops a greater overall response when
compared to C57BL/6 [23-25]. However, other authors
have shown that C57BL/6 mice also exhibit marked
pulmonary allergic inflammation compared to control
animals [20, 21, 26-29].
Previous evidence from the literature has shown that
distinct Th1-related pathologies could modulate the
inflammatory response seen in asthma [2, 5]. Therefore,
we wondered whether renal IRI could also modulate lung
function in a model of allergic inflammation.
A number of studies have revealed that robust
inflammatory responses mediated by both innate and
adaptive immune systems in postischemic kidneys are a
major factor in the pathogenesis of renal IRI.
Inflammation starts during ischemia and accelerates upon
reperfusion with endothelial activation, leukocyte
recruitment, the up-regulation of chemokines and
cytokines and the activation of the complement system.
Postischemic kidneys are not merely the passive targets
of immune-mediated injury but actively participate in the
engagement of systemic immune factors, including the
up-regulation of leukocyte adhesion molecules and toll-
like receptors (TLRs) [30]. In addition to the local damage
caused by renal IRI, distant organs can also be affected
[31], including the lungs [17, 18]. Recently, we
demonstrated that lung cellular infiltration and creatinine
levels were increased simultaneously in renal IRI [18].
However, immunized and challenge mice after renal IRI
showed reduced numbers of inflammatory cells in the
BAL fluid compared to the immunized and challenged
groups. Similar results were observed in relation to
bronchial mucus production, where renal IRI reduced the
amount of mucus in immunized and challenged mice.
Many inflammatory mediators are released during
IRI, including tumor necrosis factor and nitric oxide (NO),
which are both possible candidates for mediating the lung
dysfunction that results from intestinal IRI [32-34]. NO
seems to play an important role in asthma, not only in the
induction of the Th2 immune response but also in
amplifying and perpetuating the Th2-mediated
inflammatory response. It has been speculated that the
large amount of NO generated in the asthmatic airways
may result in the suppression of Th1 cells and a
concomitant reduction of interferon-γ (IFN-γ), leading to
the proliferation of Th2 cells [35]. In previously reported
results, we showed that after an antigen challenge, there
was transient expression of NOS2 in lung tissue, airway
cells, and BAL fluid cells and that the infiltrating
neutrophils in the airway produce NO [36]. We also
observed that the administration of L-NAME prior to the
antigen challenge significantly reduced eosinophil
infiltration and mucus production [26]. Constitutive NOS
is protective in IRI, whereas inducible NOS is responsible
for lung dysfunction [34]. Turnage et al. [37, 38]
demonstrated the deleterious role of inducible NOS in
the lung after intestinal IRI. Matsuyama et al. [39] and
Kosaka et al. [40] reported that COX-2 and iNOS are
up-regulated and have deleterious effects on renal IRI,
which is in agreement with the present results. In fact,
our group previously demonstrated that COX-2 is
important in renal damage after IRI by showing that the
blockage of COX-2 ameliorates IRI [41]. As expected,
immunized mice showed an up-regulation in COX-2 and
iNOS expression, similar to our previous findings [18].
Interestingly, in the immunized ischemic group, the levels
of COX-2 and iNOS were significantly decreased. These
results could suggest that renal IRI has a protective effect
on lung tissue, as renal IRI might attenuate the previously
established allergic lung inflammation.
The MAPK signaling cascade plays a pivotal role in
the activation of inflammatory cells. It has been shown
that the activity of p42/44 MAPK, also known as
extracellular signal-regulated kinase (ERK), in the lungs
was significantly higher in asthmatic mice than in normal
controls [9]. This pathway is involved in the activation of
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several transcription factors that control gene activity and
expression. The results presented herein showed that OA
induced ERK phosphorylation in the lung compared to
aerosol saline-treated mice. In addition, IRI/OA also
increased the phosphorylation of this signaling molecule
compared to sham-operated mice. We also analyzed PI3K,
which is composed of two subunits, a 100 kDa (p110)
catalytic subunit and an 85 kDa (p85) regulatory subunit
[42]. A direct interaction between p21ras and p110 and
the demonstration that p21ras regulates PI3‘-kinase
activity [43] suggest that the activation of p21ras could
initiate both the ERK and PI3K signaling pathways. The
data presented herein show that IRI/OA increased the
phosphorylation of ERK and Akt. This suggests that IRI
could act directly on p21ras, which favors the hypothesis
that the modulation of lung allergic responses by renal
ischemia and reperfusion injury could occur, at least in
part, by changing the activity of cellular signal transduction
factors.
To confirm this hypothesis, we evaluated the
expression levels of IL-1β, IL-2, IL-12, IL-4, IL-5 and
IL-13 because these cytokines play a critical role in
orchestrating this type of inflammatory response [44].
Some studies have demonstrated that the Th1 pattern in
IRI is deleterious, while the Th2 pattern is protective [14,
45, 46]. IL-1β, a pro-inflammatory cytokine, is involved
in endothelial activation, whereas IL-4 and IL-5 play an
essential role in the Th2 immune response [18]. In the
present study, IL-1β, IL-2 and IL-12 expression was
increased only in ischemic mice, whereas IL-4, IL-5 and
IL-13 were increased in immunized and challenged mice;
however, in asthmatic mice subjected to renal IRI, the
expression of Th2 cytokines was reduced to levels similar
to that of ischemic mice. These results corroborate
another study that demonstrated the modulation of IL-4
and IL-5 production in helminthes-infected patients with
asthma [7]. It is well known that IL-4 and IL-5 stimulate
IgE differentiation and the expression of high-affinity
IgE receptors on mast cells and eosinophilia, all of which
are involved in the pathogenesis of asthma [47]. IL-13
induces isotype switching of B cells towards
immunoglobulin°E synthesis, increases the expression of
immunoglobulin°E receptors on mast cells and causes an
up-regulation of vascular cell adhesion molecule°1, which
is implicated in the microvascular recruitment of
eosinophils and basophils. On the other hand, IRI
stimulates the synthesis of pro-inflammatory cytokines,
including IL-1, IL-6, TNF-α and IFN-γ [48, 49], and the
blockage of IL-1, IL-6, and keratinocyte-derived
chemokine (KC; a mouse analog of human IL-8) mitigates
renal injury in murine renal IRI models [50]. Marques et
al. [14] showed that IL-4 acts as a protective factor in
renal IRI. IL-4 KO mice showed reduced renal
dysfunction compared to wild-type mice, and in models
of liver and intestine ischemia and reperfusion injury, the
induction of IL-13 was cytoprotective [51, 52]. Therefore,
we could conclude that the reduced expression of IL-4,
IL-5 and IL-13 promotes the down-regulation of the lung
allergic response after renal IRI. In this model, renal IRI
modulates the lung allergic response via the Th1/Th2
balance.
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